Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 1996. Start Trial.
Date Value
September 30, 2026 28.60%
August 31, 2026 28.60%
July 31, 2026 28.60%
June 30, 2026 28.60%
May 31, 2026 28.60%
April 30, 2026 28.60%
March 31, 2026 28.60%
February 28, 2026 28.60%
January 31, 2026 28.60%
December 31, 2025 28.60%
November 30, 2025 28.60%
October 31, 2025 28.60%
September 30, 2025 28.60%
August 31, 2025 28.60%
July 31, 2025 28.60%
June 30, 2025 28.60%
May 31, 2025 28.60%
April 30, 2025 28.60%
March 31, 2025 36.60%
February 28, 2025 36.60%
January 31, 2025 36.60%
December 31, 2024 36.60%
November 30, 2024 36.60%
October 31, 2024 36.60%
September 30, 2024 36.60%
Date Value
August 31, 2024 36.60%
July 31, 2024 36.60%
June 30, 2024 36.60%
May 31, 2024 36.60%
April 30, 2024 36.60%
March 31, 2024 36.60%
February 29, 2024 36.60%
January 31, 2024 36.60%
December 31, 2023 36.60%
November 30, 2023 36.60%
October 31, 2023 36.60%
September 30, 2023 36.60%
August 31, 2023 36.60%
July 31, 2023 36.60%
June 30, 2023 36.60%
May 31, 2023 36.60%
April 30, 2023 36.60%
March 31, 2023 36.60%
February 28, 2023 36.60%
January 31, 2023 36.60%
December 31, 2022 36.60%
November 30, 2022 36.60%
October 31, 2022 36.60%
September 30, 2022 36.60%
August 31, 2022 36.60%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Labcorp Holdings, Inc. 34.60%
DaVita, Inc. 51.10%
OPKO Health, Inc. 85.55%
Psychemedics Corp. 87.72%
NeoGenomics, Inc. 91.92%